Results 111 to 120 of about 27,995 (239)

Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia

open access: yes, 2016
Santosh Bhusal,1 Sherilyn Diomampo,1 Marina N Magrey2 1Division of Rheumatology, Metrohealth Medical Center, 2Case Western Reserve University School of Medicine at Metrohealth Medical Center, Cleveland OH, USA Abstract: Fibromyalgia is a chronic ...
Diomampo S, Magrey MN, Bhusal S
core  

NOVEL PREGABALIN INTERMEDIATES AND PROCESS FOR PREPARING THEM AND PREGABALIN

open access: yes, 2007
The present invention provides novel compounds, which are especially useful as intermediates for the preparation of Pregabalin.
CASTALDI G.   +4 more
core  

Topical Alternatives for Preventing and/or Reducing Sensitivity Caused by In‐Office Tooth Bleaching: A Scoping Review

open access: yesInternational Journal of Dental Hygiene, EarlyView.
ABSTRACT Objective This scoping review aimed to (1) map, analyse, interpret and synthesize data from clinical trials on topical alternatives used to prevent and/or reduce sensitivity caused by in‐office tooth bleaching; and (2) characterize the available evidence on their use for managing sensitivity.
Erik Vinícius Martins Jácome   +3 more
wiley   +1 more source

Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report

open access: yes, 2018
Burak Kulaksizoğlu,1,2 Hüseyin Kara,1,2 Berkan Bodur,1,2 Murat Kuloğlu1,2 1Department of Psychiatry, Akdeniz University School of Medicine, Antalya, Turkey; 2Akdeniz University, Alcohol and Substance Addiction Treatment and Research Center, Antalya,
Kulaksizoğlu B   +3 more
core  

Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis

open access: yesInternational Journal of Dermatology, EarlyView.
Chronic prurigo, including prurigo nodularis, is a chronic, often treatment‐refractory condition characterized by persistent pruritus and chronic scratch lesions. Advances in the understanding of its underlying pathophysiology have enabled the development of novel targeted therapies; however, management remains challenging due to the expanding range of
Simon M. Mueller   +11 more
wiley   +1 more source

Pregabalin can cause addiction and withdrawal symptoms

open access: yes, 2015
A 38-year-old man was referred to the psychiatric department due to auditory hallucinations, suicidal ideation and a large daily intake of 8.4 g pregabalin.
Nordgaard, Julie, Jürgens, Gesche
core   +1 more source

Scalp Dysesthesia: Emerging Pathophysiologic Insights and Therapeutic Implications

open access: yesInternational Journal of Dermatology, EarlyView.
Scalp dysesthesia is a chronic condition diagnosed through exclusion. This scoping review synthesized data from 59 patients to identify recurrent clinical features, comorbidities, and management strategies that may support earlier diagnosis. Emerging patterns suggest that neuronal sensitization may underlie common symptoms.
Aditya K. Gupta   +4 more
wiley   +1 more source

BUMPS: Best use of medicines in pregnancy - Pregabalin.

open access: yes
This factsheet has been written for members of the public by the UK Teratology Information Service (UKTIS). UKTIS is a not-for-profit organisation funded by Public Health England on behalf of UK Health Departments.

core  

Medical emergency response related to MedicAtion InciDents (MERRMAID): a case series and lessons to improve medication safety

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Evidence suggests that some medical emergencies in hospital are associated with preventable medication errors or adverse reactions. Aim The purpose of this case series was to investigate and describe the proportion of Medical Emergency Response Team (MERT) activations that are medication‐related, the degree of preventability and ...
Ian Coombes   +9 more
wiley   +1 more source

Comparison of the efficacy and safety of pregabalin for postherpetic neuralgia in Chinese and international patients

open access: yes, 2018
Bruce Parsons,1 Xiaoping Pan,2 Li Xie,3 YuXuan Chen,3 Marie Ortiz,1 Ed Whalen1 1Pfizer, New York, NY, USA; 2Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province, China; 3Pfizer China, Beijing, China ...
Pan X   +5 more
core  

Home - About - Disclaimer - Privacy